Literature DB >> 25240279

Should minor strokes be excluded from intravenous thrombolysis?

Leonard L L Yeo1, Rahul Rathakrishnan, Prakash R Paliwal, Vijay K Sharma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25240279     DOI： 10.1007/s10072-014-1957-4

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


× No keyword cloud information.
  5 in total

Review 1.  Intravenous thrombolysis for minor stroke and rapidly improving symptoms: a quantitative overview.

Authors:  Qiang Huang; Qingfeng Ma; Jianping Jia; Jian Wu
Journal:  Neurol Sci       Date:  2014-07-26       Impact factor: 3.307

2.  Intravenously administered tissue plasminogen activator useful in milder strokes? A meta-analysis.

Authors:  Leonard L L Yeo; Roger Ho; Prakash Paliwal; Rahul Rathakrishnan; Vijay K Sharma
Journal:  J Stroke Cerebrovasc Dis       Date:  2014-08-10       Impact factor: 2.136

3.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

4.  Intravenous thrombolysis for acute ischemic stroke patients presenting with mild symptoms.

Authors:  Daniel Strbian; Katja Piironen; Atte Meretoja; Tiina Sairanen; Jukka Putaala; Marjaana Tiainen; Ville Artto; Kirsi Rantanen; Olli Häppölä; Markku Kaste; Perttu J Lindsberg
Journal:  Int J Stroke       Date:  2012-05-09       Impact factor: 5.266

5.  Should all patients with mild ischemic stroke be excluded from therapeutic stroke trials?

Authors:  Manoj Mittal; Marilyn Rymer; Sue-Min Lai
Journal:  J Clin Neurosci       Date:  2012-09-05       Impact factor: 1.961
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.